BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 16107222)

  • 1. Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671].
    Briel M; Christ-Crain M; Young J; Schuetz P; Huber P; Périat P; Bucher HC; Müller B
    BMC Fam Pract; 2005 Aug; 6():34. PubMed ID: 16107222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
    Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
    BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
    Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
    BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Bhatnagar N; Annane D; Reinhart K; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Lima SS; Maravić-Stojković V; Verduri A; Cao B; Shehabi Y; Beishuizen A; Jensen JS; Corti C; Van Oers JA; Falsey AR; de Jong E; Oliveira CF; Beghe B; Briel M; Mueller B
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007498. PubMed ID: 29025194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
    Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
    Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Procalcitonin-guided Antibiotics in Respiratory Infections (PARI) project in general practice - a study protocol.
    Filipsen N; Bro H; Bjerrum L; Jensen JS; Aabenhus R
    BMC Prim Care; 2022 Mar; 23(1):43. PubMed ID: 35279069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms.
    Schuetz P; Chiappa V; Briel M; Greenwald JL
    Arch Intern Med; 2011 Aug; 171(15):1322-31. PubMed ID: 21824946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.
    Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
    BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial.
    Drozdov D; Thomer A; Meili M; Schwarz S; Kouegbe RB; Regez K; Guglielmetti M; Schild U; Conca A; Schäfer P; Reutlinger B; Ottiger C; Buchkremer F; Litke A; Schuetz P; Huber A; Bürgi U; Fux CA; Bock A; Müller B; Albrich WC;
    Trials; 2013 Mar; 14():84. PubMed ID: 23522152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
    Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
    Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin for guidance of antibiotic therapy.
    Schuetz P; Albrich W; Christ-Crain M; Chastre J; Mueller B
    Expert Rev Anti Infect Ther; 2010 May; 8(5):575-87. PubMed ID: 20455686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial.
    Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
    BMJ; 2021 Sep; 374():n2132. PubMed ID: 34548312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
    Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
    Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.
    Schuetz P; Albrich W; Mueller B
    BMC Med; 2011 Sep; 9():107. PubMed ID: 21936959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.